TYVERB
Film-coated tablet, 250mg
RxActive license
Active substance (INN)
lapatinib
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength250mg
PackagingUkupno 1 bočica plastična sa 70 film tableta u kartonskoj kutiji
ManufacturerGlaxo Wellcome Operations, United Kingdom
Therapeutic groupAntineoplastic and immunomodulating agents (L01EH01)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateApril 7, 2023
Source: CInMED register